Exact Sciences and Pfizer announced today an agreement to co-promote Cologuard through 2021. According to a release, Pfizer will join Exact Sciences’ sales representatives in reaching both physicians and health…

Propeller Health announced recently that it’s collaborating with Anthem Blue Cross and Blue Shield to help improve health outcomes for Ohio consumers enrolled in Anthem’s Medicare Advantage health plans who have…

Exact Sciences broke ground on its new corporate headquarters building at University Research Park, calling it Innovation One, the company announced recently. According to a release, the 138,000 square-foot building,…

Cellectar Biosciences’ CLR 131 has been granted a Rare Pediatric Disease Designation (RPDD) for the treatment of Ewing’s sarcoma, a rare pediatric cancer, by The U.S. Food and Drug Administration…

Cellectar Biosciences today announced the effective prices of $4.00 per share of common stock of an underwritten public offering to raise approximately $16.56 million. According to a release, this includes the full…

The Madison community is important to the success of Exact Sciences, CEO Kevin Conroy said at the annual shareholder meeting held today at the Edgewater Hotel. “If you have a…

Cellectar Biosciences announced today a patient, enrolled in the CLR 131 Phase 2 trial, showed a 94 percent reduction in tumor burden and complete resolution in four of five targeted…

Gregor Diagnostics, a molecular diagnostics company developing an at-home screening test for prostate cancer, closed a $900,000 round of seed financing, the company announced recently. According to a release, the…

Zurex Pharma, a pharma and medical technology company with a novel antimicrobial technology platform, raised $9 million in advance of a pending new drug application (NDA) submission, the company announced…

Along with the $20 million funding round announced last week, Propeller Health announced recently that McKesson Ventures also has made an investment in the company. According to a release, the undisclosed…